â– LECTURE OVERVIEW: Acute stroke represents a neurological emergency. Timely differentiation between ischemic and hemorrhagic profiles is critical to determine the therapeutic pathway.
â– CLINICAL DYNAMICS:
1. Ischemic Stroke (85% of cases):
- Origin: Caused by thrombotic or embolic occlusion of a cerebral artery, most commonly the Middle Cerebral Artery (MCA).
- Cascade: Focal tissue ischemia triggers an ischemic cascade, depleting ATP, causing cellular depolarization, toxic glutamate release, and ultimate necrotic cell death.
2. Hemorrhagic Stroke (15% of cases):
- Origin: Caused by the rupture of a blood vessel in the brain parenchyma (intracerebral hemorrhage, often from long-standing hypertension eroding Charcot-Bouchard aneurysms) or into the subarachnoid space (subarachnoid hemorrhage, often from a ruptured saccular berry aneurysm).
â– PROFESSOR'S ADVANCED PATHOPHYSIOLOGY:
The cellular cascade undergoes active remodeling in response to sustained stressors. Intracellular signalling involves key phosphorylation tracks and secondary lipid messengers, culminating in altered gene transcription and structural adaptations in target tissues.
â– EPIDEMIOLOGICAL PROFILE & DENSITY CORRELATIONS:
Global burden patterns reveal notable associations with lifestyle habits, regional environmental factors, and inherited traits.
[HY-BOARD-1341]
🌟 Dynamic Clinical Key:
A non-contrast head CT scan is the absolute first-line screening diagnostic of choice. Because acute ischemia is initially invisible on CT, the main purpose is to rule out hemorrhagic stroke before administering fibrinolytic agents like recombinant tPA, which would be fatal if given during active intracranial hemorrhage. Assess patient clearance profiles (creatinine clearance and LFTs) before starting multi-drug regimens to avoid severe toxic accumulation. Focus screening efforts on high-risk geographic regions to maximize clinical yield.